Details for Patent: 11,160,786
✉ Email this page to a colleague
Which drugs does patent 11,160,786 protect, and when does it expire?
Patent 11,160,786 protects SPRITAM and is included in one NDA.
This patent has twenty patent family members in nine countries.
Drugs Protected by US Patent 11,160,786
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aprecia Pharms | SPRITAM | levetiracetam | TABLET, FOR SUSPENSION;ORAL | 207958-004 | Jul 31, 2015 | RX | Yes | Yes | 11,160,786 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
Aprecia Pharms | SPRITAM | levetiracetam | TABLET, FOR SUSPENSION;ORAL | 207958-001 | Jul 31, 2015 | RX | Yes | No | 11,160,786 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
Aprecia Pharms | SPRITAM | levetiracetam | TABLET, FOR SUSPENSION;ORAL | 207958-002 | Jul 31, 2015 | RX | Yes | No | 11,160,786 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
Aprecia Pharms | SPRITAM | levetiracetam | TABLET, FOR SUSPENSION;ORAL | 207958-003 | Jul 31, 2015 | RX | Yes | No | 11,160,786 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,160,786
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2014228990 | ⤷ Subscribe | |||
Australia | 2017202752 | ⤷ Subscribe | |||
Canada | 2906029 | ⤷ Subscribe | |||
China | 105188849 | ⤷ Subscribe | |||
China | 109908355 | ⤷ Subscribe | |||
European Patent Office | 2968994 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |